What mental illness is fluoxetine used for?
Fluoxetine is used to treat depression, obsessive-compulsive disorder (bothersome thoughts that won’t go away and the need to perform certain actions over and over), some eating disorders, and panic attacks (sudden, unexpected attacks of extreme fear and worry about these attacks).
Can you stay on fluoxetine for life?
How long will I need to take fluoxetine for? Most people take fluoxetine for at least six to 12 months after they start to feel better. If you have suffered from depression in the past, you should keep taking this medication for at least two years after you start to feel better.
Do antidepressants affect intelligence?
Serretti et al. showed that using SSRIs even in healthy individuals leads to cognitive impairment [25]. The memory loss caused by SSRIs has not yet been convincingly explained; however, serotonin appears to play an important role in learning and memory [26].
Does fluoxetine cause brain fog?
Serious side effects are rare (less than 1 in 100 people). Tell your straight away GP if any of these side effects occur: Brain fog (trouble focusing, memory problems, not thinking clearly and losing your balance can all be signs of low sodium levels)
Does fluoxetine cause memory loss?
Fluoxetine, however, showed no effect on learning and memory. It significantly reversed the scopolamine-induced memory impairment in both the tests.
Does fluoxetine improve memory?
Conclusion: Fluoxetine enhanced memory and cognition in the patients. This was consistent with previous studies that emphasized the role of fluoxetine in improving memory and promoting neurogenesis in the hippocampus.
Is fluoxetine linked to dementia?
Here, we focused on the effect of fluoxetine on AD and VaD, two of the most common types of dementia. Based on these meta-analyses, short-term SSRI treatment (<30 days) was significantly associated with increased risks of dementia compared with the placebo.
What is neuraxpharm doing in France?
Neuraxpharm today announces that its affiliate Neuraxpharm France has been selected as one of winners for the participation in a pilot program for the medical use of cannabis issued by The National Agency for the Safety of Medicines and Health Products (ANSM), together with Panaxia Labs, Israel’s largest medical cannabis manufacturer.
Who is the CEO of neuraxpharm?
Dr. Jörg-Thomas Dierks, CEO of Neuraxpharm, commented: “As we look ahead to the next chapter in Neuraxpharm’s development, the management team would like to thank Apax Partners for its support and confidence in our business over the last four years.
What is new at neuraxpharm Sweden?
The new business unit Neuraxpharm Sweden is based in Stockholm and will be led by Magnus Wassén, General Manager Neuraxpharm Nordics. On the occasion of International Epilepsy Day, Neuraxpharm promotes the digital initiative: “Life-changing Minutes”, with the aim of raising awareness about this condition and contributing to its destigmatisation.